Abstract Increased prevalence of methicillin-resistant
Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is regarded as one of the most problematic and economically relevant nosocomial-associated pathogen in the world today [11, 21] . Increased prevalence of resistance to a wide range of structurally unrelated antibiotics and antimicrobial agents has elevated this already dangerous bacteria into a multidrug-resistant MRSA [1, 33] . Current studies have shown that efflux-mediated resistance is a newly recognized and an important contributor of antibiotic resistance in bacteria, especially in MRSA isolates [18, 25] . Although nephrotoxic, vancomycin is amongst the last drugs available to treat serious MRSA infections [2] . Hence, a cause of concern is the emergence of MRSA isolates with reduced susceptibility to vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin resistant Staphylococcus aureus (VRSA) in Japan and the United States [6, 16] . As the costs are rising because of mounting mortality and the increasing drug inability, the discovery and development of new inhibitory and/or resistancemodifying agents are urgently required.
Resistance-modifying agents potentiate the activity of an antibiotic against a resistant strain as opposed to antibiotics which directly inhibit the bacteria [8, 12] . Ethidium bromide (EtBr) is a popular efflux substrate for many efflux systems while reserpine is a well-known plant-based efflux pump inhibitor (EPI) in various multidrug-resistant microorganisms, including S.aureus [13, 23, 32] . The discovery of wide-spectrum EPI (e.g. reserpine) has enabled a simple modified minimum inhibitory concentration (MIC) assay to be used for the detection of active efflux activity and as a natural product screening protocol in MRSA/S. aureus with distinctive end-point results [13, 32] . Ideally, a good bacterial efflux inhibitor must not inhibit the human P-glycoprotein involved in xenobiotic efflux of normal tissues [14] . Reserpine's toxicity and its adverse effect to humans even at low concentrations [20] limit its usage thereby warranting the quest for alternative EPIs.
This study therefore aims to systematically evaluate each alkaloid's potential as inhibitory and/or a resistancemodifying agent via efflux pump inhibition against a methicillin-sensitive S.aureus (MSSA) and five other MRSA isolates exhibiting various level of susceptibility to vancomycin.
Materials and Methods

Bacterial Isolates Used
Isolates used in this study included two American Type Culture Collection (ATCC) reference strains; ATCC 25923 (a MSSA strain) and ATCC 35931 (a MRSA strain); two clinical MRSA isolates: N441 and U949; and two labpassaged derived mutant isolates: VISA24 and VRSA156 exhibiting intermediate and high resistance towards vancomycin, respectively. Both mutants were obtained through a laboratory-passage procedure [4] with slight modification. In brief, aliquots of overnight broth cultures of four MRSA isolates, namely N391; N829; N850 and N1406 (MIC 2.5 lg/ml) [26] chosen as potential parental isolates were spread onto the surface of tryptone soy agar (TSA) plates containing increasing concentration of vancomycin and incubated at 37°C for 24 h. Surviving colonies (only further from isolate N391) were subjected to the same concentrations of vancomycin for another two cycles. This was followed with further step-wise increment in the vancomycin concentration. Eventually, a colony (coded as VISA24)-surviving vancomycin at the maximum concentration of 24 lg/ml was chosen to represent the VISA group. Similarly, another colony (coded as VRSA156)-surviving vancomycin at the maximum concentration of 156 lg/ml was chosen to represent the VRSA group. In addition, NCCLS did not provide the resistant and intermediate breakpoints for vancomycin [22] . Both mutants were subjected to antibiogram profiling using disc diffusion technique based on the NCCLS (currently known as CLSI) breakpoints [22] . Detailed identification, characterization and active efflux properties of all the S. aureus strains have been published previously [26, 27] .
Alkaloids and Chemicals Used
All the 13 alkaloid compounds listed in Table 2 ( Fig. 1) were purchased from three different suppliers namely; berberine, ephedrine, piperine, reserpine, theobromide and strychnine were from Sigma-Aldrich (St. Louis, MO, USA); colchicines and quinine were from Acros Organics (Geel, Belgium), and atropine, cinchonine, harmaline, scopolamine and papaverine from Fluka Chemie AG (Buchs, Switzerland). Ethidium bromide (EtBr) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were also from Fluka and Sigma-Aldrich, respectively, while dimethyl sulfoxide (DMSO) was from Ajax Finechem (Seven Hills, NSW, Australia).
Minimum Inhibitory Concentration (MIC) Value Determination Assay
The minimum inhibitory concentration (MIC) value determination assay was carried out to evaluate the compounds' potential as inhibitory agents against test isolate using a double-broth micro-dilution method involving 96-well microtitre-plates, as described previously [26] . In brief, serial twofold dilutions of the test compounds dissolved in dimethyl sulfoxide (DMSO) were prepared prior to the addition of 100 ll overnight microbial suspension (10 8 cfu/ml) followed by incubation at 37°C for 24 h. The highest concentration of DMSO remaining after dilution (5%, v/v) caused no inhibition of bacterial growth. The MIC value was defined as the lowest concentration producing no visible growth (absence of turbidity and or precipitation) as observed through the naked eye. For further reconfirmation, 20 ll (1 mg/ml) of 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reagent was added to the suspension in the selected wells, followed by aerobic incubation at 37°C for 20 min. The colour of the reagent-suspension will remain clear/yellowish indicative of cidal activity as opposed to dark blue indicating growth [10] .
Efflux Pump Inhibitor (EPI) Evaluation Assay
The EPI evaluation assay or modified MIC-efflux assay was carried out as previously described [27] with slight modification. Reserpine (at 50 lg/ml), a common efflux inhibitor for multidrug-resistant microorganism including S.aureus [13, 18, 32] , was used as the positive control. In brief, upon completion of the EtBr serial dilutions, each alkaloid compound at one fourth (1/4) of their respective MIC values or 50 lg/ml (for compounds with MIC values of [250 lg/ml) was added into the microbial suspensionEtBr mixture. The 50 lg/ml concentration, aside from allowing comparisons to reserpine's EPI, was also used to ensure that any noted decrease in MIC value was due to the efflux pump inactivation by the tested compound and not because of its antibacterial properties. Active efflux activity was indicated by decreased in EtBr-compound mixture's MIC value as compared to EtBr's MIC value.
Results and Discussion
MIC Value Determination Assay
All of the MRSA isolates used in this study exhibited multidrug-resistance profile against the panel of antibiotics as shown in [29] . Isolates, ATCC 33591, VISA24, and VRSA156 which are MRSAs of different susceptibility profile to vancomycin, were included to evaluate the inhibitory potential of the alkaloid compounds.
Among the chemical classes, alkaloids stand out as a class of major importance in the development of new drugs because they possess a great variety of chemical structures and have been identified as responsible for many pharmacological properties [3, 9, 15, 20] . Thirteen alkaloid compounds ( Fig. 1) were evaluated for their inhibitory potential against staphylococcal isolates differing in their susceptibility profile to antibiotics. The MIC values of these alkaloids against the respective isolates were as listed in Table 2 . Acknowledging the fact that compounds with MIC value of [200 lg/ml as weak antibacterial agents [32] , the maximum concentration limit tested in this study was set at 250 lg/ml. Berberine, a quaternary ammonium alkaloid, inhibited both isolates N441 and ATCC 25923 at 125 lg/ml thereby supporting the uses of berberine-containing plants such as Berberis vulgaris and B. aristata in many folk medicine systems, including the Ayurvedic and Chinese for the last 3000 years. More recent studies have demonstrated that berberines' higher binding affinity to other charged molecules (e.g. double-stranded DNA) due to its anionic nitrogen atom (N ? ) [5, 7] results in its notable antimicrobial activity. Apart from berberine's inhibitory activity, no other inhibition was detected amongst the remaining twelve alkaloid compounds, even at 250 lg/ml. They were then chosen as candidates for EPI evaluation assay on the premise that weak antibacterial agents are a common feature for an EPI [32] . were used as target isolates in the EPI evaluation assay based on their antibiogram profile as seen in Table 1 against three antibiotics (erythromycin, norfloxacin and tetracycline) with reported efflux-mediated properties and the presence of efflux genes (mdeA and norA) [26, 27] . A higher EtBr MIC value (250 lg/ml) was noted against U949 as compared to N441 (15.6 lg/ml) and ATCC 25923 (7.8 lg/ml). This trend matches the susceptibility profile of the three isolates against norfloxacin where U949 is resistant, N441 is of intermediate resistant and ATCC 25923 is susceptible. The similarity could be due to the presence of active pump(s) associated with both efflux substrates (EtBr and norfloxacin) in U949.
Results of the 13 weak antibacterial alkaloids evaluated for their respective EPIs potential are shown in Table 2 . Three compounds namely quinine, harmaline and piperine exhibited notable potential EPI activities. Quinine exhibited a four-fold MIC reduction in isolate N441 (from 15.6 lg/ml to 3.9 lg/ml) which was similar to reserpine; a twofold (from 250 lg/ml to 125 lg/ml) MIC reduction in isolate U949 but no changes in isolate ATCC 25923. Quinine, often present in Cinchona tree's bark has been used for the treatment of malaria in humans for over 150 years [31] . A study shows that quinine can spontaneously depolarize macrophages' plasma membrane, thereby inhibiting the H ? efflux [34] . Since all proton-mediated force (PMF)-based bacterial efflux pump systems rely on the availability of drug-ion Na
? or H ? in the cells' cytoplasmic membrane [19, 24, 34 ], quinine's potential as H ? inhibitor in S. aureus was clearly overlooked before a decade ago since its efflux-mediated resistance was not known then.
Both harmaline and piperine meanwhile recorded a notable EPI potential with eightfold EtBr MIC reduction against N441, in addition to a fourfold EtBr MIC reduction against U949 and ATCC 25923, respectively. Harmaline is an indole alkaloid from the seed of the Middle Eastern plant Harmal (Perganum harmala). Its high EtBr MIC reduction was noted through this study since it has also been reported to function as a Na
? /H ? transporter inhibitor in various organisms [19, 30, 34] . Based on these observations, we hypothesized that compounds capable of inhibiting Na
? or H ? may also function as a PMF-based bacterial EPIs. In addition, piperine, a pyridine alkaloid found in Piperaceae family (e.g. Piper nigrum L, P.longum L), has recently been reported to be involved in the inhibition of bacterial efflux pumps in S. aureus as well as MDR P-glycoprotein efflux mediated transport in rats. The mechanism of action, however, has yet to be determined [17, 28] .
With regard to the EPI potential amongst the indole alkaloids, namely harmaline, reserpine and strychnine [15] , only the former two displayed active efflux pump inhibitions. The activity may be due to the presence of a methoxy group on position C-6 of the aromatic ring coupled with a secondary amine group at the pyrrole ring in both harmaline and reserpine. Absence of both features (methoxy group at position C-6 of the aromatic ring beside a tertiary instead of secondary amine on the pyrrole ring) in strychnine probably explained its inactivity. A comparison of quinine to cinchonine of quinoline group [15] , suggest that the former could probably attribute its EPI potential to the methoxy group on the quinoline skeleton. Piperine, a piperidine alkaloid [15] , may exert its efflux inhibitory activity via the highly conjugated double bonds (conjugated diene) connected to the aromatic ring of the molecule.
The presence of aromatic ring plays an important role in efflux inhibition [14, 35] thereby explaining theobromide's (a purine-based compound) inactivity since it does not have an aromatic ring but a non-aromatic pyrimidine ring, instead. Although it is not essential [35] , most EPIs have a nitrogen atom in the middle of the molecule. As in strychnine, the presence of tertiary amine group in their respective structures renders ephedrine and colchicine (of the proto-alkaloid group), as well as papaverine and berberine (of isoquinoline alkaloid) [15] inactive. Despite the aromatic rings, the nitrogen atom in the former two compounds was positioned outside of the cyclic ring. Both atropine and scopolamine contain an exocyclic nitrogen atom, explaining the inactivity of tropane alkaloids [15] . Previous studies also suggested that lipophilic (or hydrophobic) properties, weak polar interactions provided by the overlapping of aromatic rings and the position of the nitrogen atom of efflux inhibitors, play an important role in efflux inhibition [14, 35] . The inactivity of berberine is explained by the presence of the charged nitrogen atom rendering the compound hydrophilic.
The introduction of structurally new compounds as an alternative to the existing anti-infectives enables diversification of their usages, and extend the available drugs therapy shelf-life, thereby delaying the multidrug-resistance phenomenon. Three out of thirteen alkaloid compounds that were evaluated, showed good efflux inhibitory potential against S. aureus, and this suggests that a vast number of interesting phytocompounds have yet to be discovered. Harmaline, piperine and quinine exhibited notable EPI activities warranting further pharmacodynamic and toxicology studies to ascertain their potential therapeutic application as resistance modifying agents.
